MH
DEAD

Serial Number

97412872

Owner

Monogram Health, Inc.

Attorney

Elisabeth A. Evert

First Use Date

Nov 2, 2020

Filing Date

May 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MH Trademark

Serial Number: 97412872

MH is a trademark filed by Monogram Health, Inc. on May 16, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Monogram Health, Inc. (25 trademarks)

Suite 301
Brentwood, TN 37027

Entity Type: 03

Trademark Details

Filing Date

May 16, 2022

Registration Date

Not Registered

First Use Anywhere

November 2, 2020

First Use in Commerce

November 2, 2020

Goods & Services

Medical services in the field of nephrology; behavioral health services in the nature of in-home and telehealth services in the field of nephrology; nutrition and diet counseling services for individuals experiencing chronic kidney disease or renal failure; providing wellness services, namely, personal assessments for individuals experiencing chronic kidney disease or renal failure that takes into consideration the individual's medical diagnoses, biometrics, medications and other health-related information to create a customized healthcare plan that takes into consideration the physical and behavioral health of the individual; healthcare services, namely, monitoring the biometric information of an individual experiencing chronic kidney disease or renal failure to timely intervene with medical care and medical interventions to improve the individual's medical outcome, all of the foregoing in connection with the diagnosis and treatment of renal disease and/or the provision of renal benefit management services, including the treatment and management of conditions that are co-morbid with renal disease, namely, cardiovascular disease, hypertension, lung disease, or neurological disease; none of the foregoing including the provision of medical or diagnostic testing services, or the development of diagnostic tests, to determine the drug sensitivity and drug resistance of others for diagnostic or treatment purposes

Filing History

ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Mar 12, 2025 MAB3
ABANDONMENT - AFTER EX PARTE APPEAL
Mar 11, 2025 ABN3
EXPARTE APPEAL TERMINATED
Mar 11, 2025 EXPT
EX PARTE APPEAL-REFUSAL AFFIRMED
Dec 23, 2024 EXPA
REPLY BRIEF FILED - CHECK TTAB FILES
Sep 13, 2024 RBFT
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Aug 24, 2024 GNSN
EXAMINERS STATEMENT E-MAILED
Aug 24, 2024 GNES
EXAMINERS STATEMENT - COMPLETED
Aug 24, 2024 CNES
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 25, 2024 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Feb 22, 2024 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Feb 22, 2024 GECD
ACTION CONTINUING FINAL - COMPLETED
Feb 22, 2024 CNCF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 8, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Jan 8, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 8, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 8, 2024 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 27, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 27, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 7, 2023 GNFN
FINAL REFUSAL E-MAILED
Jul 7, 2023 GNFR
FINAL REFUSAL WRITTEN
Jul 7, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 9, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 9, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 9, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 9, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 24, 2022 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 23, 2022 NWOS
NEW APPLICATION ENTERED
May 19, 2022 NWAP